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In animals, the protein kinase C (PKC) family has
expanded into diversely regulated subgroups,
including the Rho family-responsive PKN kinases.
Here, we describe knockouts of all three mouse
PKN isoforms and reveal that PKN2 loss results in
lethality at embryonic day 10 (E10), with associated
cardiovascular and morphogenetic defects. The car-
diovascular phenotype was not recapitulated by
conditional deletion of PKN2 in endothelial cells or
the developing heart. In contrast, inducible systemic
deletion of PKN2 after E7 provoked collapse of the
embryonic mesoderm. Furthermore, mouse embry-
onic fibroblasts, which arise from the embryonic
mesoderm, depend on PKN2 for proliferation and
motility. These cellular defects are reflected in vivo
as dependence on PKN2 for mesoderm proliferation
and neural crest migration. We conclude that failure
of the mesoderm to expand in the absence of PKN2
compromises cardiovascular integrity and develop-
ment, resulting in lethality.
INTRODUCTION
The Rho family guanosine triphosphatases (GTPases), which
includes Rho, Rac, and Cdc42, are regulators of cell shape,
adhesion, and motility and as such are critical in development
(Bustelo et al., 2007). Numerous studies have examined the roles
of Rho family members at a biochemical and cellular level; how-440 Cell Reports 14, 440–448, January 26, 2016 ª2016 The Authorsever, their ubiquitous expression and pleiotropic roles have
made elucidation of in vivo function difficult. This has in part
been addressed using tissue-specific conditional alleles of Rho
family members (D’Amico et al., 2009). To gain a deeper insight,
it is necessary to examine the roles of specific effector pathways.
Among the diverse array of effectors are many Ser/Thr kinases,
which include the Rho family-activated kinases (ROCK1/2),
p21-activated kinases (PAK1–PAK6), and protein kinase N
(PKN) kinases (Zhao and Manser, 2005).
The PKN kinases represent a subfamily of the protein kinase
C (PKC) family, sharing a high degree of homology within their
C-terminal kinase domains (Mukai, 2003). The divergent N-termi-
nal regulatory domains bear a C2 domain and three polybasic
coiled-coil HR1 domains, which confer binding and regulation
by Rho family members. While other mammalian PKCs lack
HR1 domains and Rho responsiveness, PKC orthologs in yeast
bear two HR1 domains and signal downstream of Rho1; yeast
PKC also retains the regulatory C1 and C2 domains found in
mammalian PKC isoforms, suggesting an evolutionary split be-
tween the Rho-responsive and the Rho-independent functions
of the PKC family. There are three PKN family members in mam-
mals (PKN1–PKN3, also known as PRKs), which vary in their
regulation. While both PKN1 and PKN2 are activated by RhoA
and Rac1 (Flynn et al., 1998; Vincent and Settleman, 1997),
they respond differently to phosphoinositides and fatty acids
(Mukai, 2003). PKN isoforms also respond to distinct stimuli
and bind to distinct effectors, highlighting functional divergence
within the family. Expression patterns also differ; PKN1 and
PKN2 mRNAs are ubiquitous in expression, while PKN3 is
more restricted to muscle, liver, and endothelial cells (Aleku
et al., 2008; Palmer et al., 1995). In vivo, a role for PKN1 in
germinal center formation has been reported (Yasui et al., 2012).
Figure 1. PKN2 Ablation Is Embryonic
Lethal and Causes Growth, Morphogenetic,
and Cardiovascular Defects
(A) PKN2/ embryos are smaller than littermates,
do not undergo axial turning, and exhibit no
branchial arches.
(B) Yolk sacs from mutant embryos have no
vitelline vessels and exhibit an immature vascular
plexus.
(C and D) Whole-mount PECAM1 staining of
E9.5 PKN2+/ and PKN2/ embryos. KO embryos
exhibit collapsed dorsal aorta and underdevel-
oped heart (boxed). The open neural tube example
(open arrowhead) and intersomitic vessel exam-
ples (closed arrowheads) are indicated.
(E–H) Transverse sections through E9.5 embryos
were subjected to endomucin staining (E and F) or
H&E (G and H). Asterisks indicate dorsal aorta in
control PKN2+/ embryos.
(I–K) Scanning electron microscopy of WT (+/+)
and PKN2/ E9.5 embryos indicating fully open
neural tube in PKN2/ embryos. Asterisks indi-
cate somites; hash mark indicates under-devel-
oped head.
Da, dorsal aorta; nt, neural tube; ng, neural groove;
nf, neural fold; ot, otic vesicle; lb, limb bud. Scale
bars represent 100 mm unless stated.Here, we report genetic ablation of all three mouse PKN iso-
forms to reveal a non-redundant essential role for PKN2 in the
developing embryonic mesenchyme.
RESULTS
PKN2 Plays a Non-redundant Role in Development
The mouse PKN1 and PKN3 genes were targeted in embryonic
stem cells (ESCs) by homologous recombination (Figure S1),
and germline transmission resulted in fertile heterozygous
mice. Gene disruption was assessed by RT-PCR and western
blot (Figures S1D–S1G). PKN1 and PKN3 crosses generated
Mendelian ratios of wild-type (WT), heterozygous, and knockout
(KO) mice (Table S1). Mice were fertile and exhibited no overtCell Reports 14, 440–448phenotype. To assess redundancy, the
PKN1 and PKN3 mice were interbred,
which generated Mendelian numbers of
healthy, fertile, double-KO mice (Table
S1).
PKN2-targeted ‘‘KO-first’’ ESCs were
obtained from the Knockout Mouse
Project (KOMP) consortium (Skarnes
et al., 2011). The KO-first strategy gener-
ates a null allele (PKN2tm1a) but allows
conversion to a conditional PKN2flox
allele through flp/FRT recombination
(PKN2tm1c; Figure S1). Germline trans-
mission was achieved with two indepen-
dent ESC clones, but crossing PKN2tm1a
heterozygotes (herein referred to as
PKN2+/) from either ESC clone gener-
ated no homozygous PKN2 KO mice(Table S1). To confirm that this results from disruption of the
PKN2 gene, the locus was flp/FRT recombined (PKN2tm1c) by
crossing with a Flp deleter mouse; recombination rescued
expression of PKN2 and survival of homozygous offspring (Table
S1). Finally, PKN2+/ mice crossed onto a PKN1/3 KO back-
ground were generated at the expected frequency with no overt
phenotype (n = 10), indicating that a single allele of PKN2 is
sufficient for embryogenesis.
PKN2 Loss Results in Embryonic Lethality by E10
Homozygous embryos derived from both independent ESC
clones died at embryonic day 10 (E10; Table S1) and failed to un-
dergo axial turning (Figure 1A). No PKN2 protein or truncated
fragments were detectable in KO E8 embryos or yolk sacs, while, January 26, 2016 ª2016 The Authors 441
PKN2+/ embryos expressed half as much PKN2, confirming
gene disruption (Figures S2A and S2B). Compressed somites
(14–18 somite pairs) in E9.5 mutant embryos demonstrate a fail-
ure to elongate, consistent with defects in convergent extension.
A lack of branchial arch formation and head development
implied a lack of mesenchymal expansion (Figures 1A and 1K).
The absence of vitelline vessels on the yolk sacs and pericardial
edema indicated a cardiovascular or angiogenic defect (Fig-
ure 1B), and the neural tube remained open to varying degrees
in all embryos (Figures 1D, 1J, and 1K). To exclude trophoblast
or placental defects as the cause of lethality, we conducted
tetraploid rescue experiments, which indicated that PKN2 is
required in the embryo or yolk sac (Figure S2C).
Immunostaining indicated ubiquitous expression of PKN2 in
E10 embryo frozen sections, with some accumulation at the api-
cal surface of the neuroepithelium and in the ectoderm (Fig-
ure S2D). LacZ reporter expression (b-galactosidase) confirmed
broad PKN2 expression (Figure S2E). qRT-PCR analysis of
PKN1 and PKN3 expression levels in E8 embryos indicated no
mRNA expression compensation in the PKN2 KOs (Figure S2F).
PKN1 and PKN2 mRNAs were both readily detectable by RNA-
scope broadly throughout the embryo.While PKN3 protein could
not be detected in embryo extracts, mRNA could be detected in
endothelial cells (as previously reported) and at low levels in
other embryo tissues (Figure S2G).
PKN2 Null Embryos Have Cardiovascular and Neural
Tube Defects
Immunostaining and histology of yolk sacs revealed an imma-
ture vascular plexus (Figures S3A and S3B) and separation of
the endodermal and mesodermal layers in PKN2 KOs (Fig-
ure S3A). These phenotypes are associated with both cardiac
and angiogenic defects. Heart and vascular development are
intrinsically linked processes, because hemodynamic force is
necessary for vascular remodeling (Lucitti et al., 2007). Substan-
tial numbers of primitive nucleated blood cells within the vascu-
lature of PKN2 KO embryos, and beating hearts, indicated that
circulation is established, typically occurring at E8.5–E9. Whole-
mount staining of the vasculature indicated collapsed major
vessels and sparse peripheral vasculature (Figures 1C and
1D). This was confirmed in transverse sections, where a disor-
ganized endothelial network is apparent throughout the mesen-
chyme (Figures 1E and 1F). Histology also revealed a delay
in cardiac looping, more typical of an embryonic heart at E8
(Figures 1G and 1H; Figure S3), further confirmed by staining
E8.5 whole-mount and transverse sections of embryo hearts
for desmin; 3D reconstructions revealed a delay in heart
morphogenesis (Figures S3C and S3D).
PKN2 KO embryos exhibit a range of neural tube defects.
Some prospective forebrain development in E9.5 embryos
was observed, with closure of the forebrain neural fold to
form a neural lumen, diencephalon, and optic vesicles (Fig-
ure S3E). The prospective hind-brain neural tube was always
open, often with no discernible neural groove. Some embryos
exhibit chranioraschischisis (Figures 1I–1K), a phenotype
associated with planar cell polarity (PCP) mutants, such as
looptail (Murdoch et al., 2001), which fail to undergo conver-
gent extension.442 Cell Reports 14, 440–448, January 26, 2016 ª2016 The AuthorsConditional PKN2flox Deletion in Either the Endothelium
or the Heart Does Not Phenocopy the Embryonic
Vascular Defect
To investigate an endothelial role, we crossed our conditional
PKN2flox mouse (PKN2tm1c; Figure S1) with the endothelial-spe-
cific Tie2-Cre (Koni et al., 2001). Tie2-Cre has been used to
uncover embryonic endothelial dependencies displaying pheno-
types similar to our PKN2 KO, including phosphatidylinositol
3-kinase p110a (Graupera et al., 2008). In contrast to global
PKN2 KO, Tie2-Cre PKN2fl/fl mice were born at Mendelian
frequency and displayed no overt phenotype (Table S2). An anal-
ysis of adult mouse retinal vasculature also revealed no discern-
ible angiogenic differences in Tie2-Cre PKN2fl/fl mice (Figures
2A–2D). Deletion was confirmed by immunoblot of mouse lung
endothelial cell lysates (Figure 2E). We conclude that PKN2 is
largely dispensable in endothelial cells. Although Tie2 is ex-
pressed in all endothelial cells (Schlaeger et al., 1997), a role
for PKN2 in endothelial precursors before Tie2-Cre recombina-
tion cannot be entirely excluded.
Mutants with severe cardiac defects, such as the contraction-
deficient MLC2a deletion (Huang et al., 2003) exhibit embryonic
vascular defects and die mid-gestation, indicating the need for
hemodynamic force in vascular remodeling (Lucitti et al.,
2007). To delete PKN2 in the embryonic heart, we crossed
PKN2flox mice with SM22a-Cre, which is expressed in the devel-
oping heart tube (from E7.5) and smooth muscle cells (Lepore
et al., 2005). SM22a-Cre-mediated PKN2 deletion shows a
partially penetrant lethal phenotype (Table S2). Surviving mice
were fertile, but pathology revealed cardiac hypertrophy, lung
fibrosis, and alveolar enlargement. To examine effects on heart
development, we collected several sets of embryos (E9.5–
E13.5). Embryo numbers were Mendelian, and KOs were indis-
tinguishable from littermates (Table S2). Transverse sections re-
vealed no gross differences in heart size or cardiomyocyte bro-
modeoxyuridine (BrdU) incorporation (Figures 2F and 2G).
Smooth muscle actin (SMA) staining also demonstrated compa-
rable smooth muscle staining of the dorsal aorta. Recombination
was confirmed by loss of PKN2 protein in adult heart ventricle
extracts (Figure 2H), and robust Cre expression throughout the
E9.5 embryo heart was confirmed by crossing with the Rosa
mTmG reporter mouse (Figure 2I). Although SM22 partial
lethality and adult pathology indicate an unexplored role for
PKN2 in the heart or smooth muscle cells, the survival of some
offspring, and the near-normal embryonic development, implies
that PKN2 is not essential for early cardiovascular function.
Inducible Deletion of PKN2 In Vivo Results in
Mesenchymal Collapse
Next, we examined the temporal requirements for PKN2 by
crossing with Rosa26 Cre-ERT2 mice (iCre; Taconic Biosci-
ences), which allows for systemic tamoxifen-induced regulation
of Cre activity in vivo. We crossed homozygous iCre PKN2fl/fl
mice with PKN2fl/+ mice to generate litters with a 1:1 ratio of
iCre (heterozygous) PKN2fl/fl:PKN2fl/+. Because PKN2+/ em-
bryos are indistinguishable from WT embryos, iCre PKN2fl/+ act
ascontrols.A singledoseof tamoxifen (3mgoral gavage) induced
loss of PKN2within 48 hr (Figure 2J). Tamoxifen administration at
E7.5wassufficient to recapitulate theaxial turningdefects inmost
Figure 2. Inducible Deletion at E6.5, but Not
Tie2-Cre or SM22a-Cre, Phenocopies the
Constitutive Knockout
(A–D) Retinal vasculature was stained for isolectin
B. Scale bars represent 500 mm (A and B) and
50 mm (C and D).
(E) Western blots indicate that endothelial PKN2 is
deleted in Tie2-Cre PKN2fl/fl mice.
(F and G) Transverse sections through E11.5
embryos reveal normal heart and major vessel
development in SM22a-Cre PKN2fl/fl embryos.
Scale bars represent 200 mm. Heart ventricle pro-
liferation (BrdU) and SMA staining of the dorsal
aorta (*) were comparable.
(H) Western blots indicate PKN2 deletion in adult
heart tissue from SM22a-Cre PKN2fl/fl mice.
(I) SM22a-Cre recombination in hearts is robust at
E9.5, as assessed by the Rosa mTmG reporter.
(J) Tamoxifen was given on day 6 or 7 of pregnancy
before embryo harvest at E9.5; PKN2 protein was
lost in PKN2fl/fl embryos at E9.5 (bottom panels).
(K and L) Deletion of PKN2 at E7.5 induced axial
turning defects in iCre PKN2fl/fl embryos.
(M and N) Transverse sections from E9.5 embryos
following E6.5 deletion were stained for H&E and
cleaved caspase 3. Littermate embryo cross
sectional area and caspase 3 pixel intensity were
measured using panoramic viewer software; data
are mean ± SD (n = 3). Open arrowheads indicate
neural crest-derived branchial arches, absent
following PKN2 deletion (M). Sections show the
otic vesicles (ov), neural tube (nt), and dorsal
aorta (da). Brightfield slide images were acquired
on a Pannoramic 250 slide scanner (3Dhistech)
and may comprise multiple instrument merged
panels.
(O) Endomucin and SMA staining revealed
collapsing vessels (arrowhead) and an unlooped
heart.
(P) PDGFRA staining confirmed mesenchymal
regression.(7/10) E9.5 PKN2fl/fl embryos (Figure 2L). Tamoxifen administra-
tion at E6.5 results in recapitulation of the gross phenotypes of
the full PKN2 KO (Figures 2M–2O). PKN2fl/fl embryos also exhibit
collapse of the mesenchyme, apoptosis, vascular disintegration
(Figures 2M–2P), and loss of branchial arches (Figures 2K–2M).
Together, our conditional KOs support a model in which the heart
and vascular defects arise secondary to a deficit within themeso-
dermal and neural crest-derived mesenchyme.
PKN2-Deficient MEFs Exhibit Proliferative and
Migratory Defects
It was not possible to derive mouse embryonic fibroblasts
(MEFs)—which derive from the embryonic mesenchyme—fromCell Reports 14, 440–448PKN2/ embryos; MEFs failed to pro-
liferate post-extraction in contrast to
littermate WT and PKN2+/ controls. To
examine the cell biological role of PKN2,
we instead derived MEFs from the iCre
PKN2fl/fl embryos and sex-matched litter-mate iCre PKN2+/+ controls. iCre PKN2+/+ MEFs allow for control
for nonspecific toxicity of 4-hydroxytamoxifen (4-OHT) or Cre in-
duction. Treatment of iCre PKN2fl/fl MEFs with 100 nM 4-OHT for
1 hr is sufficient to induce PKN2 recombination, as observed by
loss of PKN2 after 48 hr (Figure 3A). PKN2 deletion attenuated
MEF growth (Figures 3B and 3C), in line with the failure of
PKN2 null MEFs to proliferate. No decrease in cell growth was
observed for control iCre PKN2+/+ cells, and comparable results
were observed for multiple iCre PKN2fl/fl MEF lines. Growth
dependence is cell type specific, because deletion of PKN2 pro-
tein (data not shown) from iCre ESCs had no effect on growth
(Figure 3B), as expected given the normal cellular expansion dur-
ing early embryogenesis., January 26, 2016 ª2016 The Authors 443
Figure 3. PKN2Deletion Results in Reduced
Proliferation and Migration of MEFs
(A) 4-OHT treatment of iCre-PKN2 MEFs results in
dose-dependent loss of PKN2.
(B and C) 4-OHT induction results in reduced cell
viability (B) and slower growth (C) for iCre PKN2fl/fl
but not iCre PKN2 WT cells (B; n = 5; ***p < 0.001).
(B) ESC viability is not decreased by PKN2
deletion.
(D) No increase in annexin V binding, propidium
iodide uptake, sub-G1 cell fraction, or cleaved
caspase 3 (cCasp3; inset western blot) indicates
no increase in cell death following PKN2 deletion.
(E–G) Cell-cycle analysis, BrdU uptake, and
p-Histone H3 binding indicate accumulation in the
G1/G0 fraction and loss of S-phase and mitotic
cells.
(H and I) PKN2 deletion caused loss of cell-
cycle proteins. Blots were quantified relative
to GAPDH; data are mean ± SD (n = 3; p < 0.05,
**p < 0.01).
(J) 4-OHT Cre induction results in slower scratch
wound closure for iCre PKN2fl/fl but not iCre PKN2
WT cells. Mask indicates starting cell front, and
dotted lines indicate cell front after 16 hr of
migration.
(K and L) Single-cell migration speed is reduced;
cell tracks (K; axes indicate micrometers) and the
speed over the 16 hr time course are displayed (L).
Box and whiskers indicate the average, quartiles,
and range (***p < 0.001 ANOVA).
(M) Quantitative mass spectrometry (MS) analysis
and KSEA indicate broadly comparable serum-
induced activation of major signaling pathways
following PKN2 deletion. MEFs were serum
starved (0.5%) and re-stimulated (10%) for 15 min
before analysis by LC-MS/MS (n = 4). Pathway
activation (m = number of kinase substrate pep-
tides quantified) relative to control extracts is
presented as a heatmap.
(N and O) Akt, ERK, and p70S6K activation levels
in control and PKN2-depleted cells were assessed
by western blot and quantified by densitometry;
data are mean ± SD (n = 3; *p < 0.05).PKN2 loss did not result in cell death in MEFs; no increase in
annexin V staining, propidium iodide uptake, sub-G1 cells, or
cleaved caspase 3 was observed following PKN2 deletion
(Figure 3D), and non-proliferating cells remained viable
through multiple passages. This suggests that cell death
observed in the embryo is likely secondary to the death of
the embryo.
PKN2 has been reported to regulate mitotic entry and cytoki-
nesis in HeLa cells (Schmidt et al., 2007). In contrast, deletion of
PKN2 in MEFs was associated with accumulation of cells in G1/
G0 with an accompanied loss of S-phase and mitotic cells, as
assessed by BrdU incorporation, phospho-Histone (p-Histone)
H3 staining, and cell-cycle analysis (Figures 3E–3G). Decreased
expression levels of cyclin A, PCNA, and Mcm2 were consis-444 Cell Reports 14, 440–448, January 26, 2016 ª2016 The Authorstently observed, as well as decreased
levels of phosphorylated Cdk1 (Figures
3H and 3I).We reported a specific non-redundant role for PKN2 in cancer
cell migration (Lachmann et al., 2011). Comparably, scratch
wound closure rate and single-cell migration speed were
reduced following PKN2fl/fl deletion, while control iCre PKN2+/+
MEF migration was unaffected (Figures 3J–3L). The actin cyto-
skeleton, however, was largely unchanged by PKN2 deletion
(Figure S4A).
To gain an unbiased view of PKN2 signaling, we conducted
quantitative phosphoproteomic analysis. MEFs ± PKN2 were
serum starved overnight and re-stimulated with serum for
15 min before analysis by liquid chromatography-tandem mass
spectrometry (LC-MS/MS). In excess of 6,000 individual phos-
phopeptides were quantified across four biological replicates.
Ontological analysis identified numerous phosphopeptides
derived from proteins associated with cell cycle, S phase, and
mitosis that were significantly depleted in response to PKN2
loss (Table S3). These findings corroborate cell-cycle withdrawal
following PKN2 loss. We also found enrichment for phospho-
peptides associated with cytoskeletal organization (Table S4),
in line with the decreased cell motility observed here and the
known functions of the PKN kinases.
Phosphoproteomic pathway mapping through kinase sub-
strate enrichment analysis (KSEA; Casado et al., 2013; Rajeeve
et al., 2014) allows assessment of signal transduction by linking
phosphosites with their known kinases to determine pathway
activation. KSEA revealed that PKN2 loss is associated with
minimal changes in serum-induced activation of proliferative
signaling (Figures 3M and 3N). The Akt pathway was marginally
elevated under serum-starved conditions following PKN2 dele-
tion, although serum-activated Akt levels were comparable.
KSEA identified partial suppression of the p70S6K pathway.
These findings were confirmed by immunoblot, where active
p70S6K was reduced (Figures 3N and 3O), while active ERK
and Akt in serum were unchanged. This indicates that serum
growth factor coupling to key proliferative signaling axes remains
largely intact upon PKN2 deletion and identifies p70S6K as a
potential PKN2 effector pathway.
PKN2 Loss Results in Reduced Proliferation of the
ParaxialMesodermandReducedNeural CrestMigration
In Vivo
To corroborate the observed mesenchymal cell biology defects,
we conducted a series of induced deletions in the iCre PKN2
mouse. Staining of E10 embryos 48 hr after tamoxifen adminis-
tration allowed quantification of mitosis and apoptosis within
distinct tissues. Pharyngeal mesoderm displayed a significant
decrease in mitotic cells in PKN2fl/fl embryos when compared
with littermate PKN2fl/+ controls (Figures 4A and 4C). In contrast,
the branchial arch, neural tube, and heart mitotic index remained
comparable. Apoptosis in the same tissues was variable be-
tween embryos and non-tissue specific (Figures 4B and 4D).
These embryos exhibited a deficit of cephalic mesoderm and
display evidence of hemorrhage (Figure 4E). Together, these
observations support a model in which failure of the mesoderm
to proliferate results in loss of support for vascular development
and embryo death. This conclusion is reinforced by the extensive
apoptosis observed following longer periods of PKN2 deletion
(Figure 2N; data not shown).
Global PKN2KOor induced deletion before E7 results in loss of
branchial arches, which derive from both the cranial neural crest
and the cranialmesoderm (Noden andTrainor, 2005). Neural crest
cells (NCCs) delaminate from the neuroendothelium and migrate
ventrally through the mesoderm. We conducted in situ hybridiza-
tion for erbB3 in whole-mount embryos, which labels migrating
NCCs (Britsch et al., 1998). In PKN2 KO embryos, NCCs remain
close to where they delaminate instead of migrating ventrally
through the mesoderm, as in WT controls. In severe cases, in
which embryos exhibit craniorachischisis, NCCs, where detect-
able, do not migrate (Figure 4F). These data implicate PKN2 in
the development and migration of NCCs in vivo.
In summary, our findings support a mechanism by which
mesodermal and neural crest lineages acquire dependence onCPKN2 for growth and migration mid-gestation. Failure of these
lineages to expand and migrate results in loss of the physical
support required for cardiovascular integrity and development.
The critical contribution of pharyngeal mesoderm and NCCs
to the secondary heart field is also likely to contribute to the
retarded unlooped hearts in PKN2 null embryos (Plein et al.,
2015; Tzahor and Evans, 2011).
DISCUSSION
PKN kinases are emerging as regulators of cancer growth, inva-
sion, and metastasis. Despite this, and in contrast to other Rho-
activated kinases, little is known about their in vivo physiological
roles. By targeting the PKN family in vivo, we have uncovered a
non-redundant role for PKN2 during development. Here we
establish key roles in morphogenesis, lineage-specific growth,
migration, and support of cardiovascular development.
Failure to establish a circulatory system in the embryo results
in death at mid-gestation (Copp, 1995), the point at which PKN2-
null embryos die. Because this process requires interplay among
numerous co-dependent systems, unraveling cause and effect
can be challenging. Many of the genes identified as essential
for establishing circulation are those involved in heart develop-
ment and endothelial cell function; conditional KOs suggest
that PKN2 is largely dispensable here. In contrast, induced
loss of PKN2mid-gestation resulted in collapse of the embryonic
paraxial mesoderm, essential for vascular support and heart
development (Tzahor and Evans, 2011).
A role for PKN2 in the mesoderm was supported by experi-
ments with mesenchymal-derived MEFs, which depend on
PKN2 for growth and motility. In HeLa cells PKN2 regulates
mitosis (Schmidt et al., 2007), and in starfish oocytes PKN2
can directly phosphorylate (Ser209), and regulate, the key
S-phase initiator, eIF4E (Lee et al., 2000). In contrast, here, in a
physiological context, PKN2 loss was associated with arrest in
G1/G0, a decrease in S-phase and mitotic cells, and no change
in eIF4E phosphorylation (Ser209) or downstream cyclin D1
expression.
PKN2 loss also results in impaired NCC migration in vivo and
impaired MEF cell motility in vitro, in concordance with embryo
morphogenetic defects. We previously reported a non-redun-
dant role for PKN2 in bladder cancer cell migration (Lachmann
et al., 2011), perhaps shedding light on PKN2 isoform specificity.
Functionally, the actin cytoskeleton was largely unaffected by
PKN2 loss in MEFs, suggesting that RhoA regulation of actin
stress fibers is functional. Likewise, F-actin and Rac1 localized
independently of PKN2 at the leading edge of migrating cells
(Figure S4A). We did, however, identify modulation of many cyto-
skeletal components in our phosphoproteomics following PKN2
loss (Figure S4), and detailed studies on cytoskeletal dynamics
are clearly warranted.
Among the well-described pathways regulating growth and
migration in the developing embryo is the lysophosphatidic
acid (LPA) axis, where mutants (e.g., autotaxin and Ga12/13)
largely phenocopy loss of PKN2, with vascular, neural tube,
and axial turning defects (Tanaka et al., 2006; van Meeteren
et al., 2006). In support of a role in LPA signaling, deletion of
PKN2 from early-passageMEFswas found to blunt LPA-inducedell Reports 14, 440–448, January 26, 2016 ª2016 The Authors 445
Figure 4. Induced Deletion of PKN2 In Vivo
Decreases Mesodermal Proliferation and
NCC Migration
(A–E) Tamoxifen was given on day 8 of pregnancy
before embryo harvest at E10. Embryos were
sectioned and stained for p-Histone H3 (pHistH3)
to measure mitotic index and cleaved caspase 3
(cCasp3) to measure apoptotic index. (A) Aligned
sections were counted to reveal a significant
decrease in mitotic index in the pharyngeal
mesoderm (pm) but not the branchial arches (ba),
neural tube (nt), or heart (h) following PKN2 dele-
tion in PKN2fl/fl but not PKN2fl/+ embryos (n = 3;
*p < 0.05). (B) Apoptosis was variably increased
across all tissues but did not reach significance.
(C and D) Examples of pHistH3 and cCasp3 sec-
tion stains are displayed. (E) PKN2 loss results
in collapse of the cephalic mesoderm (cm) as
evidenced by hemorrhage (haem) and loss of
cellularity.
(F) Whole-mount in situ staining reveals a deficit of
migrating NCCs in PKN2 KO embryos. A single-
WT and two KO embryos are presented; / # 1
has a partially closed neural tube, whereas/ # 2
exhibits craniorachischisis. Vibratome sections
reveal a deficit of NCCs and reduced ventral
migration. Scale bars represent 100 mm.migration (Figure S4). However, no differences in LPA-induced
actin rearrangement, proliferative signaling, or transcription
(CTGF or CYR61) were observed. Thus, while PKN2 may play
some role, many aspects of LPA function remain intact.
The Rho GTPases are established regulators of convergent
extension and neural tube formation, with focus on the Wnt/
PCP pathway (Schlessinger et al., 2009). PCP pathway mutants
exhibit craniorachischisis, a severe dorsal neural tube defect
(Harris and Juriloff, 1999) also observed in PKN2/ embryos.
Closure of the forebrain neural fold, observed for our PKN2
KO, is further consistent with PCP mutants such as looptail/
vangl2 (Copp et al., 1994). Apical accumulation of Rho as a446 Cell Reports 14, 440–448, January 26, 2016 ª2016 The AuthorsPCP effector has been reported in neural
plate morphogenesis in the chick embryo
(Kinoshita et al., 2008), and PKN2 is pre-
sent in this compartment (Figure S2D).
Intriguingly, ROCK has been implicated
as a key Rho effector here in both the
mouse (Escuin et al., 2015; Ybot-Gonza-
lez et al., 2007) and the chick (Kinoshita
et al., 2008) because of sensitivity to
the ROCK inhibitor Y27632. However,
our phenotypic observations, coupled
with the reported sensitivity of PKN2 to
Y27632 inhibition (Davies et al., 2000;
Falk et al., 2014), place PKN2 as a poten-
tially important Rho effector kinase in this
context.
From an evolutionary perspective,
Drosophila has a single PKN ortholog
(dPkn), which is essential during embryo-
genesis, with mutant flies exhibiting dor-sal closure failure (Lu and Settleman, 1999). In flies, dorsal
closure occurs via a mechanism apparently requiring both
contraction of the underlying amnioserosa and migration of the
overlying epithelial layers (Jacinto et al., 2002). Considering the
parallels between Drosophila dorsal closure and mammalian
neural tube closure, it is tempting to speculate that PKN2 acts
as the mammalian ortholog to dPkn in this context.
Thegenetic ablationof thePKN family reportedhere completes
the description of KOs for the entire PKC superfamily in mice and
reveals that PKN2 is one of only two familymembers essential for
viability; atypical PKCl (PKCi inHomo sapiens) KOs also diemid-
gestation with gross morphological abnormalities (Soloff et al.,
2004). The finding that mammalian PKN2 is essential also unifies
the requirement for Rho family-responsive PKC activity from
yeast to man and highlights a surprising degree of isoform selec-
tivity within the PKN family.
EXPERIMENTAL PROCEDURES
Mice
Studies in animals were approved by the Animal Ethics Committee of the
London Research Institute (now the Francis Crick Institute) and the UK
Home Office. PKN1 and PKN3 KO mice were generated by homologous
recombination, and PKN2-targeted KO-first ESCs were purchased from
KOMP consortium. Tie2-Cre and SM22a-Cre were provided by Taija Makinen
and Ralf Adams. Rosa26CreERT2 mice (Gt(ROSA)26Sortm9(cre/ESR1)Arte)
are from Taconic Biosciences. All mice were backcrossed to a C57BL/6J
background.
Pathology and Immunostaining
Embryos and tissues were stained according to standard techniques.
For PKN1, PKN2, and PKN3 in situ staining, an RNAscope 2.0 formalin fixed
paraffin embedded assay kit was used (Advanced Cell Diagnostics) according
to the manufacturer’s instructions. Whole-mount ErbB3 in situ staining
was carried out as described elsewhere (Pryor et al., 2014). Images were ac-
quired on a 3DHISTECH slide scanner, Nikon Eclipse, or Zeiss 710 confocal
microscope.
Cell Biology and Proteomics
MEF and ESC lines were derived according to standard protocols (see the
Supplemental Information). Cell growth and viability were assessed by cell
counting and MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide). For immunoblots, proteins were resolved by SDS-PAGE, transferred
to nitrocellulose, and incubated with appropriate antibodies before enhanced
chemiluminescence visualization. For cell cycle (propidium iodide), BrdU
incorporation, and mitosis, cells were fixed in ice-cold 70% ethanol, stained
with appropriate antibodies, and assessed by fluorescence-activated cell
sorting. Migration was followed by time lapse (Essen IncuCyte). For RT-
PCR, RNA (QIAGEN) was transcribed to cDNA and amplified with TaqMan
RT and Sybr Green PCRMix (Applied Biosystems). Quantification and analysis
of phosphopeptides was performed by LC-MS/MS (Casado et al., 2013; Ra-
jeeve et al., 2014).
Statistical Methods
For two-group comparisons, statistical significance was assessed using
paired (cell cycle) or unpaired (viability, embryo quantifications, and protein
expression or phosphorylation) Student’s t tests; for multiple comparisons
(growth curves and migration), statistical significance was assessed by
ANOVA (GraphPad Prism). For phosphoproteomics, statistical significance
across four independent biological replicates was assessed with a Benjamini
and Hochberg adjusted p value < 0.05.
Full details are in the Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and four tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2015.12.049.
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